Literature DB >> 15143172

Promoter-dependent mechanism leading to selective hypomethylation within the 5' region of gene MAGE-A1 in tumor cells.

Charles De Smet1, Axelle Loriot, Thierry Boon.   

Abstract

Several male germ line-specific genes, including MAGE-A1, rely on DNA methylation for their repression in normal somatic tissues. These genes become activated in many types of tumors in the course of the genome-wide demethylation process which often accompanies tumorigenesis. We show that in tumor cells expressing MAGE-A1, the 5' region is significantly less methylated than the other parts of the gene. The process leading to this site-specific hypomethylation does not appear to be permanent in these tumor cells, since in vitro-methylated MAGE-A1 sequences do not undergo demethylation after being stably transfected. However, in these cells there is a process that inhibits de novo methylation within the 5' region of MAGE-A1, since unmethylated MAGE-A1 transgenes undergo remethylation at all CpGs except those located within the 5' region. This local inhibition of methylation appears to depend on promoter activity. We conclude that the site-specific hypomethylation of MAGE-A1 in tumor cells relies on a transient process of demethylation followed by a persistent local inhibition of remethylation due to the presence of transcription factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15143172      PMCID: PMC416434          DOI: 10.1128/MCB.24.11.4781-4790.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

1.  Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1.

Authors:  T S Weiser; Z S Guo; G A Ohnmacht; M L Parkhurst; P Tong-On; F M Marincola; M R Fischette; X Yu; G A Chen; J A Hong; J H Stewart; D M Nguyen; S A Rosenberg; D S Schrump
Journal:  J Immunother       Date:  2001 Mar-Apr       Impact factor: 4.456

2.  Alu-DNA repeat-binding protein p68 is a part of Alu-RNA containing alpha-RNP.

Authors:  D V Lukyanov; M E Urusova; K M Shcherba; O I Podgornaya
Journal:  Eur J Biochem       Date:  2000-04

Review 3.  DNA methylation patterns and epigenetic memory.

Authors:  Adrian Bird
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

4.  Imprinting and the epigenetic asymmetry between parental genomes.

Authors:  A C Ferguson-Smith; M A Surani
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

5.  Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

Authors:  J F Costello; M C Frühwald; D J Smiraglia; L J Rush; G P Robertson; X Gao; F A Wright; J D Feramisco; P Peltomäki; J C Lang; D E Schuller; L Yu; C D Bloomfield; M A Caligiuri; A Yates; R Nishikawa; H Su Huang; N J Petrelli; X Zhang; M S O'Dorisio; W A Held; W K Cavenee; C Plass
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

6.  The barrier function of an insulator couples high histone acetylation levels with specific protection of promoter DNA from methylation.

Authors:  Vesco J Mutskov; Catherine M Farrell; Paul A Wade; Alan P Wolffe; Gary Felsenfeld
Journal:  Genes Dev       Date:  2002-06-15       Impact factor: 11.361

7.  A histone H3 methyltransferase controls DNA methylation in Neurospora crassa.

Authors:  H Tamaru; E U Selker
Journal:  Nature       Date:  2001-11-15       Impact factor: 49.962

8.  Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation.

Authors:  L Jackson-Grusby; C Beard; R Possemato; M Tudor; D Fambrough; G Csankovszki; J Dausman; P Lee; C Wilson; E Lander; R Jaenisch
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

9.  DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter.

Authors:  C De Smet; C Lurquin; B Lethé; V Martelange; T Boon
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

10.  Transcription of the MAGE-1 gene and the methylation status of its Ets binding promoter elements: a quantitative analysis in melanoma cell lines using a real-time polymerase chain reaction technique.

Authors:  B L Janssen; L T van de Locht; A Fourkour; C de Smet; E J Mensink; G N van Muijen; T J de Vries
Journal:  Melanoma Res       Date:  1999-06       Impact factor: 3.599

View more
  59 in total

Review 1.  The epigenetics of breast cancer.

Authors:  Jovana Jovanovic; Jo Anders Rønneberg; Jörg Tost; Vessela Kristensen
Journal:  Mol Oncol       Date:  2010-04-29       Impact factor: 6.603

2.  Cancer-linked satellite 2 DNA hypomethylation does not regulate Sat2 non-coding RNA expression and is initiated by heat shock pathway activation.

Authors:  Gaëlle Tilman; Nausica Arnoult; Sandrine Lenglez; Amandine Van Beneden; Axelle Loriot; Charles De Smet; Anabelle Decottignies
Journal:  Epigenetics       Date:  2012-06-22       Impact factor: 4.528

3.  CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.

Authors:  S M Pulukuri; J S Rao
Journal:  Oncogene       Date:  2006-06-19       Impact factor: 9.867

Review 4.  Applying whole-genome studies of epigenetic regulation to study human disease.

Authors:  J D Lieb; S Beck; M L Bulyk; P Farnham; N Hattori; S Henikoff; X S Liu; K Okumura; K Shiota; T Ushijima; J M Greally
Journal:  Cytogenet Genome Res       Date:  2006       Impact factor: 1.636

5.  Methylation of multiple genes in gastric glands with intestinal metaplasia: A disorder with polyclonal origins.

Authors:  Mami Mihara; Yukinari Yoshida; Tetsuya Tsukamoto; Ken-ichi Inada; Yukihiro Nakanishi; Yukiko Yagi; Kohzoh Imai; Takashi Sugimura; Masae Tatematsu; Toshikazu Ushijima
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

6.  The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands.

Authors:  Hideyuki Takeshima; Satoshi Yamashita; Taichi Shimazu; Tohru Niwa; Toshikazu Ushijima
Journal:  Genome Res       Date:  2009-08-03       Impact factor: 9.043

7.  Promoter methylation of protease-activated receptor (PAR2) is associated with severe clinical phenotypes of ulcerative colitis (UC).

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Masakatsu Nakamura; Hiromi Yamashita; Daisuke Yoshioka; Masaaki Okubo; Naoko Maruyama; Toshiaki Kamano; Yoshio Kamiya; Hiroshi Fujita; Yoshihito Nakagawa; Mitsuo Nagasaka; Masami Iwata; Kazuya Takahama; Makoto Watanabe; Hiroshi Nakano; Ichiro Hirata; Tomiyasu Arisawa
Journal:  Clin Exp Med       Date:  2009-01-30       Impact factor: 3.984

8.  Chronic aspirin use suppresses CDH1 methylation in human gastric mucosa.

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Masakatsu Nakamura; Hiromi Yamashita; Daisuke Yoshioka; Masaaki Okubo; Naoko Maruyama; Toshiaki Kamano; Yoshio Kamiya; Hiroshi Fujita; Mitsuo Nagasaka; Masami Iwata; Kazuya Takahama; Makoto Watanabe; Ichiro Hirata; Tomiyasu Arisawa
Journal:  Dig Dis Sci       Date:  2009-01-29       Impact factor: 3.199

9.  MAGE-A1 expression is associated with good prognosis in neuroblastoma tumors.

Authors:  Elena Grau; Silvestre Oltra; Francisco Martínez; Carmen Orellana; Adela Cañete; Jose María Fernández; Miguel Hernández-Martí; Victoria Castel
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-27       Impact factor: 4.553

10.  Development of a novel output value for quantitative assessment in methylated DNA immunoprecipitation-CpG island microarray analysis.

Authors:  Satoshi Yamashita; Kosuke Hosoya; Ken Gyobu; Hideyuki Takeshima; Toshikazu Ushijima
Journal:  DNA Res       Date:  2009-09-18       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.